Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 19,632 | 14,919 | 9,834 | 26,544 | 11,236 |
| Gross Profit | 19,632 | 14,919 | 9,834 | 26,544 | 11,236 |
| Operating Expenses | 81,811 | 103,650 | 65,996 | 35,093 | 32,313 |
| Operating Income | -62,179 | -88,731 | -56,162 | -8,549 | -21,077 |
| Other Income | 1,702 | 1,852 | -5,064 | -60 | 125 |
| Pre-tax Income | -60,477 | -86,879 | -61,226 | -8,609 | -20,952 |
| Income Tax | N/A | N/A | N/A | -8,273 | 1,445 |
| Net Income Continuous | -60,477 | -86,879 | -61,226 | -336 | -22,397 |
| Net Income | $-60,477 | $-86,879 | $-61,226 | $-336 | $-22,397 |
| EPS Basic Total Ops | -1.46 | -2.59 | -28.77 | -0.04 | -3.80 |
| EPS Basic Continuous Ops | -1.46 | -2.59 | -28.77 | -0.04 | -3.79 |
| EPS Diluted Total Ops | -1.46 | -2.59 | -28.77 | -0.04 | -3.80 |
| EPS Diluted Continuous Ops | -1.46 | -2.59 | -28.77 | -0.04 | -3.79 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.59 | 1.00 | -1.60 | -3.00 |
| EBITDA(a) | $-58,825 | $-84,611 | $-51,732 | $23,236 | $-20,955 |